SOPHiA GENETICS SA

Good morning, my name is Joelle and I will be your conference operator today.

At this time, I would like to welcome everyone to the Sophia Genetics second quarter 2026 earnings conference call. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, August 4th, 2026. I would now like to turn the conference over to Kellen Sanger, Sophia Genetics head of the

Thank you, and good morning, everyone. Welcome to the Sophia Genetics Second Quarter 2026 Earnings Conference Call. Joining me today to discuss the results are Ross Muken, our Chief Executive Officer, and George Cardoza, our Chief Financial Officer. I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Thank you for joining us. We will present both IFRS and non-IFRS financial measures. A reconciliation of IFRS and non-IFRS measures is included in today's earnings press release, which is available on our website. With that, I'll now turn the call over to Ross.